Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adult urological sarcoma.

P Russo1, M S Brady, K Conlon

  • 1Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021.

The Journal of Urology
|April 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Conservative management of complete traumatic pancreatic body transection; A case report.

International journal of surgery case reports·2020
Same author

Attitudes of oncology healthcare practitioners towards smoking cessation: A systematic review of the facilitators, barriers and recommendations for delivery of advice and support to cancer patients.

Radiography (London, England : 1995)·2017
Same author

Segmental duodenal resection: indications, surgical techniques and postoperative outcomes.

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract·2015
Same author

Radical cystectomy and orthotopic urinary reconstruction in patients with bladder cancer after renal transplantation: clinical outcomes and description of technique.

Transplantation proceedings·2013
Same author

Bedside sphincterometry.

Urology·2011
Same author

Selecting clinical research projects for the urologic oncologist.

Urologic oncology·2011
Same journal

On the Memoryless Property in Markov Models for NMIBC Cost-Effectiveness Analysis.

The Journal of urology·2026
Same journal

Multi-institutional Assessment of Performance Metrics for MRI-targeted Transperineal Prostate Biopsy.

The Journal of urology·2026
Same journal

Urinary Supersaturation in a Randomized Trial among Individuals with Recurrent Nephrolithiasis comparing Empiric versus Selective Preventive Therapy: The URINE Trial.

The Journal of urology·2026
Same journal

The FDA Should Allow More BCG Strains into the US Market: How Recent Landmark Trials Expose a Regulatory Paradox.

The Journal of urology·2026
Same journal

Let's Shift the Focus from Death to Life after Fournier's Gangrene.

The Journal of urology·2026
Same journal

Endourology and Nephrolithiasis.

The Journal of urology·2026
See all related articles

Urological sarcomas are rare, often high-grade tumors. Complete surgical resection is key for better survival, and advanced stages may benefit from adjuvant treatments.

Area of Science:

  • Oncology
  • Surgical Pathology
  • Medical Statistics

Background:

  • Soft tissue sarcomas are rare malignancies.
  • Urological and male genital tract sarcomas represent a small subset of these tumors.
  • Understanding their characteristics is crucial for effective management.

Purpose of the Study:

  • To analyze the incidence, characteristics, and outcomes of urological sarcomas.
  • To identify prognostic factors for relapse-free survival.
  • To evaluate the utility of the Memorial Sloan-Kettering Cancer Center (MSKCC) sarcoma staging system.

Main Methods:

  • Retrospective review of adult patients with soft tissue sarcoma at MSKCC from July 1982 to December 1989.
  • Analysis of tumor site, histology, grade, size, and metastatic status.

Related Experiment Videos

  • Assessment of surgical resection completeness and survival rates.
  • Application of the MSKCC sarcoma staging system.

    • Main Results:

    • 43 urological sarcomas were identified (2.7% of soft tissue sarcomas).
    • Common sites included paratesticular, prostate/seminal vesicle, bladder, and kidney.
    • Leiomyosarcoma and rhabdomyosarcoma were the most frequent histologies.
    • High grade (86%) and large size (>5 cm, 56%) were common.
    • Complete resection was achieved in 58% of patients.
    • 3-year and 5-year relapse-free survival rates were 55% and 40%, respectively.
    • Favorable prognostic factors included smaller tumor size, low grade, specific sites (paratesticular, bladder), and complete resection.
    • Stages 3 and 4 had a combined 3-year relapse-free survival of 26%.

    Conclusions:

    • Urological sarcomas are aggressive tumors with significant relapse rates.
    • Complete surgical resection is a critical factor for improved outcomes.
    • The MSKCC sarcoma staging system effectively predicts survival.
    • Patients with advanced stage (3 or 4) urological sarcomas may benefit from adjuvant therapy.